PDF herunterladen
CC BY-NC-ND 4.0 · J Lab Physicians 2022; 14(01): 099-100
DOI: 10.1055/s-0041-1736479
Letter to the Editor

The Monster Tuberculosis in India, Impending Epidemic in COVID-19 Era

Rahul Garg 
1   Section of Infectious Diseases, Department of General Medicine, All India Institute of Medical Sciences Bhopal, Bhopal, Madhya Pradesh, India
,
Alkesh Kumar Khurana
2   Department of Pulmonary Medicine & TB, All India Institute of Medical Sciences Bhopal, Bhopal, Madhya Pradesh, India
,
Sagar Khadanga
1   Section of Infectious Diseases, Department of General Medicine, All India Institute of Medical Sciences Bhopal, Bhopal, Madhya Pradesh, India
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
   Lizenzen und Reprints

The World Health Organization (WHO) estimated 10 million tuberculosis (TB) cases with 1.6 million TB-related deaths worldwide in 2019. WHO also identifies India harboring approximately 26% of the global TB cases.[1] Eliminating TB worldwide is undoubtedly dependent on India. Identifying this concern, the Prime Minister of India launched the “National Tuberculosis Elimination Program (NTEP)” to eliminate TB in the country by 2025.

The ongoing COVID-19 pandemic with new variants of concern and interests caused by the severe acute respiratory syndrome coronavirus 2 has thrown the world into disarray, with over 170 million people reportedly infected nearly 4 million deaths globally.[2] As the COVID-19 pandemic worsened in 2020–21, the already weakened global TB campaign worsened considerably, and the low- and medium-income countries, including India, are the worst hit.[3] The prevalence of TB among COVID-19 patients is 0.37 to 4.47% in different studies.[4] However, we believe that this is an understatement and the true prevalence is often beyond imagination. Our assumption is based on the following observations.



Publikationsverlauf

Artikel online veröffentlicht:
23. November 2021

© 2021. The Indian Association of Laboratory Physicians. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India